Sign in
4

Changes in Ownership

IMPACT BIOMEDICAL INC. Filed Acc 0001493152-24-048579

Chief Executive Officer bought 500 shares at $2.61 ($1,305)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Heuszel Frank D Chief Executive Officer 2024-11-27 Purchase +500 $2.61 $1,305 96,844 D: show line 1 in the form
Open-market purchases · 500 sh · avg $2.61 · $1,305
Loading xslF345X05/ownership.xml…